Digital Technical and Informal Resources of Breast Cancer Patients From 2012 to 2020: Questionnaire-Based Longitudinal Trend Study.

breast cancer digitalization eHealth internet

Journal

JMIR cancer
ISSN: 2369-1999
Titre abrégé: JMIR Cancer
Pays: Canada
ID NLM: 101666844

Informations de publication

Date de publication:
18 Nov 2021
Historique:
received: 02 06 2020
accepted: 10 03 2021
revised: 23 08 2020
entrez: 18 11 2021
pubmed: 19 11 2021
medline: 19 11 2021
Statut: epublish

Résumé

Digitalization offers enormous potential in medicine. In the era of digitalization, the development of the use of digital, technical, and informal resources of breast cancer patients and factors influencing the degree of digitization of patients has been insufficiently researched. The aim of this study was to assess the development of the use of digital technical and informal resources in a well-defined patient cohort. A longitudinal study on 513 breast cancer patients from 2012 to 2020 was conducted using a questionnaire that included the main aspects of the degree of digitalization, including digital device availability and use, stationary and mobile internet access and use, and communication and information seeking regarding breast cancer diagnosis and treatment. The majority of patients (421/513, 82.1%) owned the technical resources to benefit from eHealth, used the internet to obtain information (292/509, 57.4%), and were willing to use new eHealth solutions (379/426, 89%). Two-thirds of the patients discussed information about their cancer on the internet with their doctor, one-third found additional treatment options on the internet, and 15.3% (44/287) of the patients stated that this had changed their cancer therapy. The degree of digitization is increasing yet still significantly depends on 3 factors: (1) age (whereas 100% [39/39] of the <59-year-old group used the internet in 2020, 92% of the 60 to 69-year-old group [11/12] and only 47% [6/13] of the >70-year-old group used the internet), (2) education (internet use significantly depended on education, as only 51.8% [59/114] of patients with primary school education used the internet, but 82.4% [126/153] with middle school education and 90.3% [213/236] with high school education used the internet; P<.001), and (3) household size (67.7% [111/164] of patients living alone used the internet, whereas 84.7% [287/339] of patients living in a house with ≥2 people used the internet; P<.001). To implement digital solutions in health care, knowledge of the composition and degree of the use of digital technical and informal resources of the patient group for which the respective solution is developed is crucial for success. German Register of Clinical Studies DRKS00012364; https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00012364.

Sections du résumé

BACKGROUND BACKGROUND
Digitalization offers enormous potential in medicine. In the era of digitalization, the development of the use of digital, technical, and informal resources of breast cancer patients and factors influencing the degree of digitization of patients has been insufficiently researched.
OBJECTIVE OBJECTIVE
The aim of this study was to assess the development of the use of digital technical and informal resources in a well-defined patient cohort.
METHODS METHODS
A longitudinal study on 513 breast cancer patients from 2012 to 2020 was conducted using a questionnaire that included the main aspects of the degree of digitalization, including digital device availability and use, stationary and mobile internet access and use, and communication and information seeking regarding breast cancer diagnosis and treatment.
RESULTS RESULTS
The majority of patients (421/513, 82.1%) owned the technical resources to benefit from eHealth, used the internet to obtain information (292/509, 57.4%), and were willing to use new eHealth solutions (379/426, 89%). Two-thirds of the patients discussed information about their cancer on the internet with their doctor, one-third found additional treatment options on the internet, and 15.3% (44/287) of the patients stated that this had changed their cancer therapy. The degree of digitization is increasing yet still significantly depends on 3 factors: (1) age (whereas 100% [39/39] of the <59-year-old group used the internet in 2020, 92% of the 60 to 69-year-old group [11/12] and only 47% [6/13] of the >70-year-old group used the internet), (2) education (internet use significantly depended on education, as only 51.8% [59/114] of patients with primary school education used the internet, but 82.4% [126/153] with middle school education and 90.3% [213/236] with high school education used the internet; P<.001), and (3) household size (67.7% [111/164] of patients living alone used the internet, whereas 84.7% [287/339] of patients living in a house with ≥2 people used the internet; P<.001).
CONCLUSIONS CONCLUSIONS
To implement digital solutions in health care, knowledge of the composition and degree of the use of digital technical and informal resources of the patient group for which the respective solution is developed is crucial for success.
TRIAL REGISTRATION BACKGROUND
German Register of Clinical Studies DRKS00012364; https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00012364.

Identifiants

pubmed: 34792468
pii: v7i4e20964
doi: 10.2196/20964
pmc: PMC8663592
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e20964

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

©Christoph A Mallmann, Christian M Domröse, Lars Schröder, David Engelhardt, Frederik Bach, Helena Rueckel, Alina Abramian, Christina Kaiser, Alexander Mustea, Andree Faridi, Wolfram Malter, Peter Mallmann, Christian Rudlowski, Oliver Zivanovic, Michael R Mallmann. Originally published in JMIR Cancer (https://cancer.jmir.org), 18.11.2021.

Références

Breast. 2016 Apr;26:31-45
pubmed: 27017240
JMIR Aging. 2019 Mar 26;2(1):e11451
pubmed: 31518256
JMIR Cancer. 2016 Mar 09;2(1):e2
pubmed: 28410177
Cancer. 2020 Jan 15;126(2):408-415
pubmed: 31580497
JMIR Aging. 2020 Jun 3;3(1):e15491
pubmed: 32490837
J Thorac Oncol. 2019 Jun;14(6):1012-1020
pubmed: 30776447
Circ Cardiovasc Qual Outcomes. 2018 Jul;11(7):e004420
pubmed: 30006474
BMJ Open. 2019 Sep 17;9(9):e030863
pubmed: 31530612
JMIR Cancer. 2017 Sep 28;3(2):e15
pubmed: 28958985
Diabetes Technol Ther. 2016 Feb;18(2):59-67
pubmed: 26645932
High Blood Press Cardiovasc Prev. 2016 Sep;23(3):187-96
pubmed: 27072129
J Med Internet Res. 2020 Feb 7;22(2):e16144
pubmed: 32031538
Acta Oncol. 2020 Aug;59(8):967-974
pubmed: 32427015
Am J Prev Med. 2018 Apr;54(4):576-583
pubmed: 29456025
J Cancer Surviv. 2021 Feb;15(1):87-98
pubmed: 32671557
JMIR Mhealth Uhealth. 2017 Jun 14;5(6):e81
pubmed: 28615159
J Med Internet Res. 2020 Apr 17;22(4):e16768
pubmed: 32301740
J Cancer Surviv. 2019 Apr;13(2):197-204
pubmed: 30756225
J Med Internet Res. 2019 Mar 14;21(3):e10348
pubmed: 30869638
Med Care. 2016 Aug;54(8):772-9
pubmed: 27314262

Auteurs

Christoph A Mallmann (CA)

Department of Surgery, University Hospital of Cologne, Cologne, Germany.
Center of Integrated Oncology Aachen, Köln, Bonn, Düsseldorf, Cologne, Germany.

Christian M Domröse (CM)

Center of Integrated Oncology Aachen, Köln, Bonn, Düsseldorf, Cologne, Germany.
Department of Obstetrics & Gynecology, University Hospital of Cologne, Cologne, Germany.

Lars Schröder (L)

Department of Obstetrics & Gynecology, University Hospital of Cologne, Cologne, Germany.
Department of Obstetrics & Gynecology, Klinikum Hanau, Hanau, Germany.

David Engelhardt (D)

Center of Integrated Oncology Aachen, Köln, Bonn, Düsseldorf, Cologne, Germany.
Department of Obstetrics & Gynecology, University Hospital of Cologne, Cologne, Germany.

Frederik Bach (F)

Center of Integrated Oncology Aachen, Köln, Bonn, Düsseldorf, Cologne, Germany.
Department of Obstetrics & Gynecology, University Hospital of Cologne, Cologne, Germany.

Helena Rueckel (H)

Center of Integrated Oncology Aachen, Köln, Bonn, Düsseldorf, Cologne, Germany.
Breast Center, University Hospital of Bonn, Bonn, Germany.

Alina Abramian (A)

Center of Integrated Oncology Aachen, Köln, Bonn, Düsseldorf, Cologne, Germany.
Breast Center, University Hospital of Bonn, Bonn, Germany.

Christina Kaiser (C)

Center of Integrated Oncology Aachen, Köln, Bonn, Düsseldorf, Cologne, Germany.
Breast Center, University Hospital of Bonn, Bonn, Germany.

Alexander Mustea (A)

Center of Integrated Oncology Aachen, Köln, Bonn, Düsseldorf, Cologne, Germany.
Department of Gynecology & Gynecologic Oncology, University Hospital of Bonn, Bonn, Germany.

Andree Faridi (A)

Center of Integrated Oncology Aachen, Köln, Bonn, Düsseldorf, Cologne, Germany.
Breast Center, University Hospital of Bonn, Bonn, Germany.

Wolfram Malter (W)

Center of Integrated Oncology Aachen, Köln, Bonn, Düsseldorf, Cologne, Germany.
Department of Obstetrics & Gynecology, University Hospital of Cologne, Cologne, Germany.

Peter Mallmann (P)

Center of Integrated Oncology Aachen, Köln, Bonn, Düsseldorf, Cologne, Germany.
Department of Obstetrics & Gynecology, University Hospital of Cologne, Cologne, Germany.

Christian Rudlowski (C)

Department of Obstetrics & Gynecology, Evangelic Hospital Bergisch Gladbach, Bergisch Gladbach, Germany.

Oliver Zivanovic (O)

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, United States.

Michael R Mallmann (MR)

Center of Integrated Oncology Aachen, Köln, Bonn, Düsseldorf, Cologne, Germany.
Department of Obstetrics & Gynecology, University Hospital of Cologne, Cologne, Germany.

Classifications MeSH